Varian

At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. Because, for cancer patients everywhere, their fight is our fight.
(1)

For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 10,000 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. For more information, visit http://www.varian.com.

12/30/2025

Investing in global health is a long-term commitment—and we’re in it for the long haul.

While our collaboration in Kenya with Moi Teaching and Referral Hospital and IU Health has made incredible strides in expanding access, we know the journey is far from over.

Through education, empowerment, and the strengthening of local expertise, the community is building an ecosystem that will enable it to thrive for generations to come.

Together, we’re building a future where healthcare is accessible to everyone, everywhere, and sustained by shared commitment. https://cbsn.ws/3KHLLjY

QR700031713

12/26/2025

For cervical cancer patients, adaptive brachytherapy provides highly targeted and personalized treatment options. This technique using advanced hybrid applicators has been shown to reduce toxicities and improve outcomes in gynecological cancers.*

Despite that, adoption of this important technique is limited in lower-middle-income countries where cervical cancer burden is highest, largely due to lack of training.

Earlier this year, Varian Medical Affairs supported a hands-on workshop at INCAN — Guatemala’s largest cancer center — where clinicians discussed image-guided adaptive brachytherapy workflows using Varian’s Aarhus Applicator Set. Now, INCAN is routinely utilizing this treatment workflow, an important milestone for both providers and the ~600 cervical cancer patients the cancer center sees each year.

Training drives access. Technology enables impact. Together, they transform care.

* EMBRACE II – a multicenter prospective interventional cohort study on IGRT-IMRT + cisplatin + MR-IGABT in locally advanced cervical cancer: overall results. https://bit.ly/4b6FTvc

QR700032115

12/23/2025

Long-term, committed collaborations are strengthening cancer care around the globe.

In Eldoret, Kenya, the radiology department used to be a branch of the surgery department—staffed by just one radiologist. It has since grown into a fully operational department with 12 radiologists and a comprehensive set of modern treatment tools.

At the heart of this progress is a simple but powerful belief: the foundation of good care starts with building a strong local team.

Our collaboration with Teaching and Referral Hospital and IU Health is focused on just that; ensuring that expertise grows from within rather than relying only on external support. https://cbsn.ws/3KHLLjY

QR700031713

12/19/2025

💡SGRT Spotlight🔦

The radiation oncology department at the Hamamatsu University School of Medicine in Japan treats about 600 patients annually for most disease sites, including cranial sites and head and neck squamous cell carcinoma.

After ten years of research into surface-guided radiation therapy (SGRT) solutions, Professor Nakamura and his team found what they were looking for in IDENTIFY: "We wanted a motion management solution that would fully integrate with the TrueBeam and offer excellent patient monitoring."

In this case study, https://bit.ly/48B9n2S, uncover how IDENTIFY for SGRT has helped Professor Nakamura and his team:
🔸 Enhance patient positioning accuracy, including real-time monitoring and motion management
🔸Perform non-invasive verification
🔸Reduce patient setup time with tattooless workflows and faster treatment times
🔸Improve respiratory motion management, including use of breath hold techniques
🔸Enable the exploration of maskless SRS treatments
🔸Increase patient comfort

The statement by Varian’s customer described here is based on results achieved in the customer’s unique clinical setting. Because there is no “typical” clinical setting and many variables exist, there is no guarantee that other customers will achieve the same results.
QR700032013

12/18/2025

“A world without fear of cancer” ... “We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably.”

These aren’t just the mission statements of Varian and Siemens Healthineers, they’re promises.

And thanks to our deep collaboration with Moi Teaching and Referral Hospital and IU Health, cancer patients in Kenya are experiencing what happens when these promises become reality.

The camaraderie between these institutions is breaking down some of the biggest barriers to cancer care in Kenya. There is now hope for patients who once faced delayed diagnosis or who had to travel hundreds of kilometers for care.

This is just the beginning. https://bit.ly/48KYkEh

QR700031713

12/16/2025

A significant moment for cancer care in the UK as Cancer Centre London begins treating its first patient using RapidArc Dynamic technology - the first centre in the UK to offer this advanced radiotherapy capability. This achievement reflects a shared commitment to expanding access to high-quality care and supporting patients and their families throughout their journey.

Congratulations to the Icon team on reaching this important milestone. We’re proud to collaborate with Icon Group, who is dedicated to enhancing the patient experience and bringing world-class care closer to local communities.

12/15/2025

Congratulations to Beacon Hospital , the first center in Ireland to treat a patient using Varian’s RapidArc Dynamic technology.

This milestone represents an important step forward for radiotherapy in the region. RapidArc Dynamic is designed to help clinicians deliver more personalized treatment with greater precision and efficiency, supporting improved workflows and patient care.

At Varian, a Siemens Healthineers company, we’re proud to collaborate with Beacon Hospital’s radiotherapy team as they continue to drive innovation and patient outcomes in Ireland.

Well done to the entire Beacon Hospital team for this achievement and for their ongoing commitment to advancing cancer care.

QR700032668

12/11/2025

🌍 Scalable Innovation in Cancer Care

Advanced tech is reaching more patients, in more places:
• Pelvic radiation planning with HyperSight* CBCT imaging
• Head & neck precision in resource-limited settings
• Abdominal imaging despite motion and implants

🔗 Explore how scalable solutions are closing the care gap. https://bit.ly/4qUoziv

*HyperSight is an optional feature on Varian’s TrueBeam, Edge, Halcyon, and Ethos systems.

QR700030955

12/11/2025

Reducing time in the treatment room can help improve both patient comfort and workflow efficiency. Precision, comfort and confidence are key factors shaping the patient experience, and every improvement matters.

Turning this vision into reality starts here: SainteCatherine, Institut du Cancer - AvignonProvence leads the way as the first center in Europe to implement the full Halcyon 5.0 ecosystem. With advanced real-time motion management, high-quality embedded imaging, and smoother, more precise patient positioning, these advancements support more personalized treatment delivery while helping clinical teams work with greater ease and confidence.

This milestone reflects a shared commitment to making radiotherapy not only more precise, but also more human by improving the experience for patients and supporting the clinicians who care for them.

Learn more about how we’re shaping the future of cancer care: https://bit.ly/48NYoSA

Halcyon 5.0 and Identify 5.0 are not available for sale in all markets.
QR700032647

12/10/2025

Varian and Telix have announced a strategic clinical collaboration to develop new clinical applications that combine Telix’s theranostic products with external beam radiation therapy (EBRT).

The initial investigational focus is PSMA-PET imaging for prostate cancer radiotherapy patients. Telix and Varian will assess how Illuccix® and Gozellix® may support patient selection for EBRT, inform personalized treatment planning, and monitor response to treatment.

The collaboration also creates a framework for broader future co-development across Telix’s pipeline, including TLX250-CDx (Zircaix®) and TLX01-CDx (Pixclara®). By combining radiopharmaceuticals with EBRT, the companies aim to support radiation oncologists in delivering more precise, targeted cancer care.

Read more on our website here: https://bit.ly/4pYSODD

TLX250-CDx and TLX101-CDx have not received a marketing authorization in any jurisdiction. Zircaix and Pixclara brand names subject to final regulatory approval.
QR700032752

12/04/2025

Stereotactic spinal radiosurgery is already delivering powerful results—but what if it could be even faster, more precise, and easier to plan?

A new study from 台大醫院 National Taiwan University Hospital Cancer Center comparing conventional VMAT with RapidArc Dynamic* in a cohort of ten cervical spine metastasis patients, researchers uncovered significant improvements in both modulation and efficiency with RapidArc Dynamic.

✅ Sharper dose fall-off and enhanced conformity
✅ 30% fewer monitor units for faster treatment
✅ 80% shorter planning time
✅ A general, though statistically non-significant, reduction in dose to normal tissues

RapidArc Dynamic streamlines the entire process—with the goal of enhancing outcomes for patients while optimizing workflows for clinicians.
Read the full article to see how RapidArc Dynamic is establishing a new approach in stereotactic spinal radiosurgery. https://bit.ly/47YOOx0

The results of this study were achieved in the study’s unique setting. Because there is no “typical” clinical setting and many variables exist, there is no guarantee that customers will achieve the same results.

*RapidArc Dynamic is an optional feature.
Not available for sale in all markets.
QR700031180

12/03/2025

💡SGRT Spotlight🔦

Image Guided Radiation Therapy (IGRT) treats about 30 patients a day for all kinds of tumors and cancer cells, using advanced treatment technologies that include Varian Edge, RapidArc, Eclipse, and IDENTIFY.

In this case study, https://bit.ly/3KfdacD uncover how IDENTIFY for surface-guided radiation therapy (SGRT) has helped Dr. Desjardin, Dr. Puranik, and Dr. Luo and their team:
🔸Move to tattooless treatments after just two cases, improving patient comfort and clinical efficiency
🔸Establish an expanding lung SBRT treatment program due to confidence in IDENTIFY setup and motion management accuracy
🔸Switch to weekly MV portal images to reduce imaging dose to patients
🔸Simplify patient setup for complex cases, including electron treatments and SRS
🔸Reduce treatment times, allowing the clinic to treat more patients daily and respond to growing radiotherapy needs within the community

The statement by Varian’s customer described here is based on results achieved
in the customer’s unique clinical setting. Because there is no “typical” clinical
setting and many variables exist, there is no guarantee that other customers
will achieve the same results.

QR700031905

Address

3100 Hansen Way
Palo Alto, CA
94304

Telephone

+16504934000

Website

http://www.varian.com/

Alerts

Be the first to know and let us send you an email when Varian posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Palo Alto?

Varian

12/30/2025

12/26/2025

12/23/2025

12/19/2025

12/18/2025

12/16/2025

12/15/2025

12/11/2025

12/11/2025

12/10/2025

12/04/2025

12/03/2025

Address

Telephone

Website

Alerts

Shortcuts

Share

Category